Evidence map›Paper›PMID 38969974›Full record

ArticleBMC cardiovascular disorders2024

Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data.

Fardad Soltani, David A Jenkins, Amit Kaura, Joshua Bradley, Nicholas Black, John P Farrant, Simon G Williams, Abdulrahim Mulla, Benjamin Glampson, Jim Davies and 22 more

Abstract readMulticenter StudyComparative Study
In one paragraph

Article in BMC cardiovascular disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Fardad SoltaniDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
David A JenkinsDivision of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Amit KauraNIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary's Hospital, London, W2 1NY, UK.
Joshua BradleyDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Nicholas BlackDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
John P FarrantDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Simon G WilliamsManchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester, M23 9LT, UK.
Abdulrahim MullaNIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary's Hospital, London, W2 1NY, UK.
Benjamin GlampsonNIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary's Hospital, London, W2 1NY, UK.
Jim DaviesNIHR Oxford Biomedical Research Centre, University of Oxford and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Dimitri PapadimitriouNIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary's Hospital, London, W2 1NY, UK.
Kerrie WoodsNIHR Oxford Biomedical Research Centre, University of Oxford and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Anoop D ShahLondon Biomedical Research Centre, NIHR University College, University College London and University College London Hospitals NHS Foundation Trust, London, UK.
Mark R ThurszNIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary's Hospital, London, W2 1NY, UK.
Bryan WilliamsLondon Biomedical Research Centre, NIHR University College, University College London and University College London Hospitals NHS Foundation Trust, London, UK.
Folkert W AsselbergsLondon Biomedical Research Centre, NIHR University College, University College London and University College London Hospitals NHS Foundation Trust, London, UK.
Erik K MayerNIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary's Hospital, London, W2 1NY, UK.
Christopher HerbertNIHR Leeds Clinical Research Facility, Leeds Teaching Hospitals Trust and University of Leeds, Leeds, UK.
Stuart GrantNIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, University of Manchester, Manchester, UK.
Nick CurzenNIHR Southampton Clinical Research Facility and Biomedical Research Centre, Faculty of Medicine, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Iain SquireNIHR Biomedical Research Centre, Glenfield Hospital, Leicester, LE3 9QP, UK.
Thomas JohnsonNIHR Bristol Biomedical Research Centre, University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Kevin O'GallagherKing's College London British Heart Foundation Centre of Excellence and King's College Hospital NHS Foundation Trust, London, UK.
Ajay M ShahKing's College London British Heart Foundation Centre of Excellence and King's College Hospital NHS Foundation Trust, London, UK.
Divaka PereraBritish Heart Foundation Centre of Excellence, School of Cardiovascular Medicine and Sciences, King's College London, London, UK.
Rajesh KharbandaNIHR Oxford Biomedical Research Centre, University of Oxford and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Riyaz S PatelLondon Biomedical Research Centre, NIHR University College, University College London and University College London Hospitals NHS Foundation Trust, London, UK.
Keith M ChannonNIHR Oxford Biomedical Research Centre, University of Oxford and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Richard LeeNIHR Biomedical Research Centre, The Royal Marsden and Institute of Cancer Research, London, UK.
Niels PeekDivision of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Jamil MayetNIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary's Hospital, London, W2 1NY, UK.
Christopher A MillerDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, UK. Christopher.Miller@manchester.ac.uk.

Funding

BHF Imperial Centre for Research Excellence RE/18/4/34215British Heart Foundation AA/18/4/34221British Heart Foundation AA/18/6/24223British Heart Foundation FS/20/18/34972British Heart Foundation FS/CRA/22/23036National Institute for Health and Care Research AI_AWARD01864National Institute for Health and Care Research NIHR301338UK Research and Innovation Horizon Europe Guarantee for DataTools4Heart
6 · The paper itself

Abstract

backgroundHeart failure (HF) with preserved or mildly reduced ejection fraction includes a heterogenous group of patients. Reclassification into distinct phenogroups to enable targeted interventions is a priority. This study aimed to identify distinct phenogroups, and compare phenogroup characteristics and outcomes, from electronic health record data.

methods2,187 patients admitted to five UK hospitals with a diagnosis of HF and a left ventricular ejection fraction ≥ 40% were identified from the NIHR Health Informatics Collaborative database. Partition-based, model-based, and density-based machine learning clustering techniques were applied. Cox Proportional Hazards and Fine-Gray competing risks models were used to compare outcomes (all-cause mortality and hospitalisation for HF) across phenogroups.

resultsThree phenogroups were identified: (1) Younger, predominantly female patients with high prevalence of cardiometabolic and coronary disease; (2) More frail patients, with higher rates of lung disease and atrial fibrillation; (3) Patients characterised by systemic inflammation and high rates of diabetes and renal dysfunction. Survival profiles were distinct, with an increasing risk of all-cause mortality from phenogroups 1 to 3 (p < 0.001). Phenogroup membership significantly improved survival prediction compared to conventional factors. Phenogroups were not predictive of hospitalisation for HF.

conclusionsApplying unsupervised machine learning to routinely collected electronic health record data identified phenogroups with distinct clinical characteristics and unique survival profiles.

Indexed as

Electronic Health RecordsHeart FailureStroke VolumeVentricular Function, LeftAgedAged, 80 and overCause of DeathComorbidityDatabases, FactualData MiningFemaleHospitalizationHumansMaleMiddle AgedPhenotypeElectronic health recordsHeart failure with preserved or mildly reduced ejection fractionMachine learning

Identifiers

PMID38969974
PMCPMC11229019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.